Andrew Drechsler's most recent trade in Baudax Bio Inc was a trade of 39,473 Common Stock done . Disclosure was reported to the exchange on June 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baudax Bio Inc | Andrew Drechsler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 39,473 | 41,656 (0%) | 0% | 0 | Common Stock |